Cash Flow

v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash from operating activities:    
Net income (loss) $ 44,169 $ (743,104)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 41,132 19,071
Stock option expense 21,892
Changes in assets and liabilities:    
Accounts receivable (2,084,943) (1,115,965)
Contract assets 921,608 (184,494)
Prepaid expenses and other current assets 91,898 53,029
Operating lease right of use asset (557,485)
Accounts payable 643,916 (22,436)
Payroll taxes payable (156,843) 8,608
Accrued expenses 26,265 (69,837)
Operating lease obligation 571,245
Contract liabilities (999,048) 522,172
Deferred revenue (63,965) (94,957)
Net cash used in operating activities (1,500,159) (1,627,913)
Cash flows from investing activities:    
Software development costs (60,000)
Purchase of patents/trademarks (3,000) (1,000)
Purchase of fixed assets (88,511) (63,113)
Net cash used in investing activities (91,511) (124,113)
Cash flows from financing activities:    
Repayments of line of credit (921) (301)
Repayments of related party notes (48,215)
Repayments of insurance and equipment financing (64,295) (74,435)
Proceeds from warrants exercised 1,650,000
Net cash provided (used in) by financing activities 1,584,784 (122,951)
Net decrease in cash (6,886) (1,874,977)
Cash, beginning of period 1,209,301 1,941,818
Cash, end of period 1,202,415 66,841
Supplemental Disclosure of Cash Flow Information:    
Interest paid 1,536 3,519
Supplemental Non-Cash Investing and Financing Activities:    
Common stock issued for accrued BOD fees 73,709
Note issued for financing of insurance premiums $ 165,864

Source